Multi-site Collaborative Cancer Clinical Trials Groups

The Australian Government is supporting Australia’s capacity to develop industry-independent cancer clinical trial protocols. The following Multi-site Collaborative Cancer Clinical Trials Groups are currently funded by Cancer Australia:

  •     Australasian Gastro-Intestinal Trials Group
  •     Australasian Leukaemia and Lymphoma Group
  •     Australasian Lung Cancer Trials Group
  •     Australia and New Zealand Melanoma Trials Group
  •     Australia New Zealand Gynaecological Oncology Group
  •     Australian and New Zealand Children’s Haematology and Oncology Group
  •     Australian and New Zealand Urogenital and Prostate Cancer Trials Group
  •     Australian New Zealand Breast Cancer Trials Group
  •     Australasian Sarcoma Study Group
  •     Breast Cancer Trials
  •     Cooperative Trials Group for Neuro-Oncology
  •     Primary Care Collaborative Cancer Clinical Trials Group
  •     Psycho-Oncology Co-operative Research Group
  •     Trans-Tasman Radiation Oncology Group

The primary aim of the funding is to support the Groups to develop industry-independent cancer clinical trial protocols.  The broader program objectives are to:

  • Increase the number of cancer clinical trials conducted in Australia
  • Increase the participation in clinical trials by people affected by cancer
  • Increase the number of clinical sites actively participating in cancer clinical trials
  • Increase the involvement of policy makers, clinicians, researchers and consumers in the development of cancer clinical trials
  • Increase Australia’s Multi-site Collaborative Clinical Trials Group participation in national multi-group or international cancer clinical trials in Australia